Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
KRISHGEN BIOSYSTEMS Immunoassay for the estimation of Pembrolizumab in serum and plasma. Can be used for generics and biosimilar mAb PK studies. Assay Range: 10 - 640 ng/ml; Sensitivity: 8.25 ng/ml.
Supplier: KRISHGEN BIOSYSTEMS KBI1084
Pack Size: 1 x 96 wells. Background: Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, and cervical cancer. It is an immune checkpoint inhibitor against PD-L1, inhibiting lymphocytes' PD-1 receptors, blocking the ligands that would deactivate it and prevent an immune response. It is on the World Health Organization's List of Essential Medicines. This mAb-based Pembrolizumab ELISA accurately quantifies pembrolizumab and biosimilars in human samples. If you are looking to use animal samples, please contact us. ELISA Features include a pre-coated plate with break-apart wells, standardisation and Lot to Lot Consistency with Precision CV <15%.
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction